
Published: 11 months ago
Size: 585.4KB
The third of Stem Cell RegenCo's podcasts will bring you more up-to-date information on our stem cell research program. Stem cell RegenCo has obtained exclusive rights to the proprietary stem cell regeneration treatment for liver disease developed by the International Institute of Biological Medicine, IIBM, in Moscow. Their clinically proven STEM CELL LIVER REGENERATION (SCLR) program can restore 90 to 95% of the physiological functions of a liver damaged by cirrhosis, Hepatitis B and Hepatitis C. The transplantation procedure is a non-invasive series of injections that requires an average in-hospital stay of seven days. This non-invasive procedure is perfect for the treatment of children. This ground-breaking therapy is now available to ten patients a month only through Stem Cell RegenCo. In this podcast we will be answering a few of the questions sent to us by those interested in our treatment program.

Published: 11 months ago
Size: 1.2MB
In this podcast, we will be discussing the availability of a donor liver for transplantation, Stem Cell RegenCo's advanced non-invasive stem cell treatment for cirrhosis, hepatitis B, hepatitis C and several case studies.

Published: 11 months ago
Size: 1.0MB
The first of Stem Cell RegenCo's podcasts will bring you the most up-to-date information on our stem cell research program. Stem cell RegenCo has obtained exclusive rights to the proprietary stem cell regeneration treatment for liver disease developed by the International Institute of Biological Medicine, IIBM, in Moscow. Their clinically proven STEM CELL LIVER REGENERATION (SCLR) program can restore 90 to 95% of the physiological functions of a liver damaged by cirrhosis, Hepatitis B and Hepatitis C. The transplantation procedure is a non-invasive series of injections that requires an average in-hospital stay of seven days. This non-invasive procedure is perfect for the treatment of children. This ground-breaking therapy is now available to ten patients a month only through Stem Cell RegenCo. In this podcast we will be answering a few of the questions sent to us by those interested in our treatment program.